-+ 0.00%
-+ 0.00%
-+ 0.00%

Roth Capital Reiterates Buy on SANUWAVE Health, Lowers Price Target to $47

Benzinga·03/30/2026 18:03:55
Listen to the news
Roth Capital analyst Kyle Bauser reiterates SANUWAVE Health (NASDAQ:SNWV) with a Buy and lowers the price target from $53 to $47.